Lorelei D. Shoemaker, Ph.D.
Affiliations: | University of California, Los Angeles, Los Angeles, CA |
Area:
Neural stem cells, development, brain tumorsGoogle:
"Lorelei Shoemaker"Mean distance: 17.11 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Harley I. Kornblum | grad student | 2006 | UCLA | |
| (From genes to proteins: A proteomics analysis of cortical neural stem and progenitor cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shoemaker LD, McCormick AK, Allen BM, et al. (2020) Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations. Clinical and Translational Medicine |
| Shoemaker LD, Kornblum HI. (2015) Neural stem cell diversity and proteomics. Molecular & Cellular Proteomics : McP |
| Shoemaker LD, Fuentes LF, Santiago SM, et al. (2014) Human brain arteriovenous malformations express lymphatic-associated genes. Annals of Clinical and Translational Neurology. 1: 982-95 |
| Eckermann JM, Krafft PR, Shoemaker L, et al. (2012) Potential application of hydrogen in traumatic and surgical brain injury, stroke and neonatal hypoxia-ischemia. Medical Gas Research. 2: 11 |
| Shoemaker LD, Orozco NM, Geschwind DH, et al. (2010) Identification of differentially expressed proteins in murine embryonic and postnatal cortical neural progenitors. Plos One. 5: e9121 |
| Nakano I, Masterman-Smith M, Saigusa K, et al. (2008) Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. Journal of Neuroscience Research. 86: 48-60 |
| Cheng JC, Horwitz EM, Karsten SL, et al. (2007) Report on the workshop "New Technologies in Stem Cell Research," Society for Pediatric Research, San Francisco, California, April 29, 2006. Stem Cells (Dayton, Ohio). 25: 1070-88 |